Location History:
- San Francisco, CA (US) (2012 - 2014)
- Mountain View, CA (US) (2012 - 2016)
Company Filing History:
Years Active: 2012-2016
Title: Innovations by David B. Rosen: Pioneering Methods in Cellular Analysis
Introduction
David B. Rosen is an accomplished inventor based in Mountain View, California, who has contributed significantly to the field of biomedical research. With a total of seven patents to his name, Rosen's work focuses on advancing methodologies for cellular analysis, which holds great potential in the diagnosis and treatment of diseases.
Latest Patents
One of Rosen's latest inventions is centered around methods for diagnosis, prognosis, and treatment. This invention presents an innovative approach for determining the activation states of various proteins in single cells. By enabling rapid detection of heterogeneity in complex cell populations, the method facilitates the identification of cellular subsets with correlated changes in activation. Moreover, this invention allows researchers to correlate cellular activities or properties effectively. Notably, diseases such as Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS), and Myeloproliferative Neoplasms (MPN) can be analyzed using this advanced approach.
Additionally, Rosen has developed a high-throughput flow cytometry system and method, which includes systems, compositions, kits, and methodologies for the automated processing of biological samples and their analysis via flow cytometry. This innovation streamlines the workflow in biological research, enhancing the efficiency and accuracy of sample analysis.
Career Highlights
David B. Rosen is currently employed by Nodality, Inc., a company dedicated to improving patient outcomes through advanced technologies in biomedical research. His role has positioned him at the forefront of innovative solutions in the healthcare industry, contributing to significant advancements in precision medicine.
Collaborations
Throughout his career, Rosen has collaborated with distinguished colleagues, including Wendy Fantl and Alessandra Cesano. These partnerships have fostered a dynamic environment for research and innovation, leading to the production of impactful inventions that benefit the scientific community and patient care.
Conclusion
In summary, David B. Rosen stands out as an influential inventor whose contributions to cellular analysis are shaping the biomedical industry. His patents reflect a commitment to harnessing technology for better diagnostic and therapeutic methods, particularly in the context of serious diseases. With ongoing collaborations and a solid foundation at Nodality, Inc., Rosen continues to drive innovations that promise to revolutionize patient care and research methodologies.